Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?
Completed
Alcon Research
Phase 2/Phase 3
2009-02-01
The investigators hypothesize that intracameral Triesence during glaucoma surgery will
provide lower intraocular pressure through better control of ocular inflammation, thus
leading to a more successful filtering procedure.
Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?
Completed
Wills Eye
Phase 2/Phase 3
2009-02-01
The investigators hypothesize that intracameral Triesence during glaucoma surgery will
provide lower intraocular pressure through better control of ocular inflammation, thus
leading to a more successful filtering procedure.
Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular Edema
Completed
Hospital Universitario de Canarias
Phase 3
2010-10-01
This clinical trial is designed to investigate differences in terms of efficacy (mean change
in best corrected visual acuity obtained after 12 months of treatment) and safety, of 3
therapeutic estrategies for non-tractional macular edema in diabetic patients: a) laser
alone; b) laser plus tiramcinolon; and c) laser plus bevacizumab.
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Completed
Clearside Biomedical, Inc.
Phase 1/Phase 2
2013-02-01
This study is designed to determine the safety and tolerability of a single microinjection of
triamcinolone acetonide (TRIESENCE®) into the suprachoroidal space (SCS) of patients who have
non-infectious uveitis.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
